Managing vasomotor symptoms effectively without hormones.

Climacteric : the Journal of the International Menopause Society
C A McCormickM Hickey

Abstract

Vasomotor symptoms (hot flushes and/or night sweats) affect approximately 80% of women over the menopause transition and can affect quality of life, productivity, and relationships. Vasomotor symptoms are the main reason for seeking treatment during the menopausal transition. Although menopausal hormone therapy (MHT) is effective for symptom management, the majority of symptomatic women do not take MHT. In this article, we review the evidence for non-hormonal treatments for vasomotor symptoms, including pharmacological and non-pharmacological approaches, and provide a clinical algorithm for managing symptomatic women.

References

Mar 31, 1986·The Medical Journal of Australia·B G Wren, L B Brown
Feb 20, 1998·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·D L BartonP Novotny
Nov 26, 2005·Journal of General Internal Medicine·Nancy KimHarlan M Krumholz
Dec 3, 2005·Maturitas·Lolkje T W de Jong-van den BergPaul B van den Berg
Sep 24, 2008·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gary ElkinsTimothy Keith
May 6, 2009·Climacteric : the Journal of the International Menopause Society·N BigliaP Sismondi
Nov 11, 2009·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles L LoprinziKelli N Burger
Jan 20, 2011·JAMA : the Journal of the American Medical Association·Ellen W FreemanAndrea Z LaCroix
Sep 14, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Annelies H BoekhoutJan H M Schellens
Sep 1, 2012·Journal of General Internal Medicine·Janet S CarpenterMenggang Yu
Feb 26, 2013·Menopause : the Journal of the North American Menopause Society·Gary R ElkinsTimothy Z Keith
Jul 19, 2013·Menopause : the Journal of the North American Menopause Society·Jennifer L MarinoMartha Hickey
Sep 21, 2013·Menopause : the Journal of the North American Menopause Society·James A SimonJoel Lippman
Oct 24, 2013·Menopause : the Journal of the North American Menopause Society·JoAnn V PinkertonUNKNOWN Breeze 3 Investigators
Feb 6, 2014·Menopause : the Journal of the North American Menopause Society·David R WalegaPauline M Maki
Feb 27, 2014·Menopause : the Journal of the North American Menopause Society·James A SimonAndrew E Denker
Jul 1, 2014·Menopause : the Journal of the North American Menopause Society·Rebecca C ThurstonMichele D Levine
Jul 9, 2014·Menopause : the Journal of the North American Menopause Society·Hsiao-Yean ChiuPei-Shan Tsai
Dec 18, 2014·BJOG : an International Journal of Obstetrics and Gynaecology·A J DaleyC MacArthur
Feb 17, 2015·JAMA Internal Medicine·Nancy E AvisUNKNOWN Study of Women's Health Across the Nation
May 20, 2015·Maturitas·Gesthimani MintzioriMargaret Rees
Jul 15, 2015·International Journal of Gynaecology and Obstetrics : the Official Organ of the International Federation of Gynaecology and Obstetrics·Mojgan RahmanianRaheb Ghorbani
Oct 31, 2015·Climacteric : the Journal of the International Menopause Society·J S CarpenterA Z LaCroix
Nov 12, 2015·Climacteric : the Journal of the International Menopause Society·S L GoughnourF Linkov
Feb 14, 2016·Climacteric : the Journal of the International Menopause Society·R J BaberUNKNOWN IMS Writing Group
Jan 1, 2015·Nature Reviews. Disease Primers·Susan R DavisTommaso Simoncini
Jun 22, 2016·JAMA : the Journal of the American Medical Association·Oscar H FrancoTaulant Muka
Oct 26, 2016·Menopause : the Journal of the North American Menopause Society·James A SimonUNKNOWN Extended-Release Oxybutynin Therapy for VMS Study Group
Jul 14, 2017·Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists·Rhoda H CobinUNKNOWN AACE Reproductive Endocrinology Scientific Committee
Sep 13, 2017·JAMA : the Journal of the American Medical Association·JoAnn E MansonUNKNOWN WHI Investigators
Oct 19, 2017·Climacteric : the Journal of the International Menopause Society·J K Prague, W S Dhillo
Nov 25, 2017·BMJ : British Medical Journal·Martha HickeyMyra S Hunter
Jan 2, 2018·Oncotarget·Julia K Prague, Waljit S Dhillo
Feb 18, 2018·Maturitas·Holger CramerRomy Lauche
Mar 9, 2018·Endocrine Reviews·George A BrayThomas H Inge
Feb 5, 2019·Climacteric : the Journal of the International Menopause Society·M BirkhaeuserY Ramos

❮ Previous
Next ❯

Citations

Sep 4, 2020·The Journal of Clinical Endocrinology and Metabolism·Richard J SantenCynthia A Stuenkel
Apr 2, 2021·Seminars in Reproductive Medicine·Annabelle Brennan, Martha Hickey
Apr 15, 2021·Current Oncology Reports·Bethânia Soares Dos SantosDaniela Dornelles Rosa

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.

Related Papers

Obstetrics and Gynecology
American College of Obstetricians and Gynecologists Women's Health Care Physicians
Przegla̜d menopauzalny = Menopause review
Areti AugouleaKonstantinos Panoulis
Maturitas
Pauliina Tuomikoski, Hanna Savolainen-Peltonen
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
Stephanie TranPaul A Cohen
© 2021 Meta ULC. All rights reserved